Natural killer cell surveillance of intracellular antigen processing pathways mediated by recognition of HLA-E and Qa-1b by CD94/NKG2 receptors

Microbes and Infection

Volumn 2, Issue 4, 2000, Pages 371-380

  O'Callaghan, Christopher A ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

C lectin; CD94; HLA E; Immune recognition; NK cells; NKG2; Qa 1b

Indexed keywords

CD94 ANTIGEN; HLA E ANTIGEN;

ANTIGEN BINDING; ANTIGEN PRESENTATION; ANTIGEN RECOGNITION; HLA SYSTEM; HUMAN; NATURAL KILLER CELL; PRIORITY JOURNAL; RECEPTOR BINDING; REVIEW;

EID: 0034054189     PISSN: 12864579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1286-4579(00)00330-0     Document Type: Review

References (37)

1. Aldrich C.J., Decloux A., Woods A.S., Cotter R.J., Soloski M.J., Forman J. Identification of a Tap-dependent leader peptide recognized by alloreactive T cells specific for a class Ib antigen. Cell. 79:1994;649-658.
2. Henderson R.A., Michel H., Sakaguchi K., Shabanowitz J., Appella E., Hunt D.F., Vh E. HLA-A2. 1-Associated peptides from a mutant cell line: a second pathway for antigen presentation. Science. 255:1992;1264-1266.
3. Trowsdale J., Hanson I., Mockridge I., Beck S., Townsend A., Kelly A. Sequences encoded in the class II region of the MHC related to the ABC superfamily of transporters. Nature. 348:1990;741-744.
4. Spies T., Cerundolo V., Colonna M., Cresswell P., Townsend A.R.M., Demars R. Presentation of viral antigen by MHC class I molecules is dependent on a putative peptide transport heterodimer. Nature. 355:1992;644-646.
5. Cotterill L.A., Stauss H.J., Millrain M.M., Pappin D.J.C., Rahman D., Canas B., Chandler P., Stackpoole A., Simpson E., Robinson P.J., Dyson P.J. Qa-1 interaction and T cell recognition of the Qa-1 determinant modifier peptide. Eur. J. Immunol. 27:1997;2123-2132.
6. Kurepa Z., Forman J. Peptide binding to the class Ib molecule Qa-1b. J. Immunol. 158:1997;3244-3251.
7. Decloux A., Woods A.S., Cotter R.J., Soloski M.J., Forman J. Dominance of a single peptide bound to the Class Ib molecule Qa-1b. J. Immunol. 158:1997;2183-2191.
8. Connolly D.J., Coterill L.A., Hederer R.A., Thorpe C.J., Travers P.J., McVey J.H., Dyson J., Robinson P.J. A cDNA clone encoding the mouse Qa-1a histocompatibility antigen and proposed structure of the putative peptide binding site. J. Immunol. 151:1993;6089-6098.
9. Lee N., Goodlett D.R., Ishitani A., Marquardt H., Geraghty D.E. HLA-E surface expression depends on binding of TAP-dependent peptides derived from certain HLA class I signal sequences. J. Immunol. 160:1998;4951-4960.
10. Ulbrecht M., Kellerman J., Johnson J.P., Weiss E.H. Impaired intracellular transport and cell surface expression on non polymorphjic HLA-E: evidence for inefficient peptide binding. J. Exp. M. 176:1992;1083-1090.
11. O'Callaghan C.A., Tormo J., Willcox B.E., Blundell C.D., Jakobsen B.K., Stuart D.I., McMichael A.J., Bell J.I., Jones E.Y. Production, crystallization and preliminary X-ray analysis of the human class Ib MHC molecule HLA-E. Protein Science. 7:1998;1264-1266.
12. Elvin J., Potter C., Elliott T., Cerundoo V., Townsend A.R.M. A method to quantify binding of unlabelled peptides to class I MHC alleles and detect their allele specificity. J. Immunol. Methods. 158:1993;161.
13. Braud V., Jones E.Y., McMichael A.J. The human major histocompatibility complex class Ib molecule HLA-E binds signal sequence derived peptides with primary anchor residues at positions 2 and 9. Eur. J. Immunol. 27:1997;1164-1169.
14. Braud V., Allan D.S., Wilson D., McMichael A.J. TAP and tapasin-dependent HLA-E surface expression correlates with the binding of an MHC class I leader peptide. Curr. Biol. 8:1998;1-10.
15. O'Callaghan C.A., Bell J.I. Structure and function of the human MHC class Ib molecules HLA-E, HLA-F and HLA-G. Immunol. Rev. 163:1998;129-138.
16. Altman J.D., Moss P.A.H., Goulder P.J.R., Barouch D.H., McHeyzer-Williams M.G., Bell J.I., McMichael A.J., Davis M.M. Phenotypic analysis of antigen-specific T lymphocytes. Science. 274:1996;94-96.
17. O'Callaghan C.A., Byford M.F., Wyer J.R., Willcox B.E., Jakobsen B.K., McMichael A.J., Bell J.I. BirA enzyme: Production and application in the study of membrane receptor-ligand interactions by site-specific biotinylation. Analyt. Biochem. 266:1999;9-15.
18. McMichael A.J., O'Callaghan C.A. A new look at T cells. J. Exp. M. 187:1998;1367-1371.
19. Braud V., Allan D.S.J., O'Callaghan C.A., Ogg G.S., Lazetic S., Young N.T., Bell J.I., Phillips J.H., Lanier L.L., McMichael A.J. HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C. Nature. 391:1998;795-799.
20. Borrego F., Ulbrecht M., Weiss E.H., Coligan J.E., Brooks A.G. Recognition of Human Histocompatibility Leukocyte antigen (HLA)-E complexed with HLA class I signal sequence-derived peptides by CD94/NKG2 confers protection from natural killer cell-mediated lysis. J. Exp. M. 187:1998;813-818.
21. Lee N., Llano M., Carretero M., Ishitani A., Navarro F., Lopez-Botet M., Geraghty D.E. HLA-E is a major ligand for the NK inhibitory receptor CD94/NKG2A. Proc. Natl. Acad. Sci. USA. 95:1998;5199-5204.
22. Salcedo M., Bousso P., Ljunggren H.G., Kourilsky P., Abastado J.P. The Qa-1b molecule binds to a large subpopulation of murine NK cells. Eur. J. Immunol. 28:1998;4356-4361.
23. Vance R.E., Kraft J.R., Altman J.D., Jensen P.E., Raulet D.H. Mouse CD94/NKG2A is a natural killer cell receptor for the nonclassical major histocompatibility complex (MHC) class I molecule Qa-1b. J. Exp. M. 188:1998;1841-1848.
24. Lazetic S., Chang C., Houchins J.P., Lanier L.L., Phillips J.H. Human natural killer cell receptors involved in MHC class I recognition are disulphide-linked heterodimers of CD94 and NKG2 subunits. J. Immunol. 157:1996;4741-4745.
25. Phillips J.H., Chang C., Mattson J., Gumperz J.E., Parham P., Lanier L.L. CD94 and a novel associated protein (94AP) form a NK cell receptor involved in the recognition of HLA-A, HLA-B and HLA-C allotypes. Immunity. 5:1996;163-172.
26. Carretero M., Palmiari G., Llano M., Tullio V., Santoni A., Geraghty D.E., Lopez-Botet M. Specific engagement of the CD94/NKG2A killer inhibitory receptor by the HLA-E class Ib molecule induces SHP-1 phosphatase recruitment to tyrosine-phosphorylated NKG2-A: evidence for receptor function in heterologous transfectants. Eur. J. Immunol. 28:1998;1-12.
27. Houchins J.P., Lanier L.L., Niemi E.C., Phillips J.H., Ryan J.C. Natural killer cell cytolytic activity is inhibited by NKG2-A and activated by NKG2-C. J. Immunol. 158:1997;3603-3609.
28. Lanier L.L., Corliss B., Wu J., Phillips J.H. Association of DAP12 with activating CD94/NKG2C NK cell receptors. Immunity. 8:1998;693-701.
29. Ulbrecht M., Modrow S., Srivastava R., Peterson P.A., Weiss E.H. Interaction of HLA-E with peptides and the peptide transporter in vitro: implications for its function in antigen presentation. J. Immunol. 160:1998;4375-4385.
30. Llano M., Lee N.I., Navarro F., Garcia P., Albar J.P., Geraghty D.E., Lopez-Botet M. HLA-E bound peptides influence recognition by inhibitory and triggering CD94/NKG2 receptors: preferential response to an HLA-G derived nonamer. Eur. J. Immunol. 28:1998;2854-2863.
31. Brooks A.G., Borrego F., Posch P.E., Patamawenu A., Scorzelli C.J., Ulbrecht M., Weiss E.H., Coligan J.E. Specific recognition of HLA-E, but not classical HLA class I molecules by soluble CD94/NKG2A and NK cells. J. Immunol. 162:1999;305-313.
32. Vales-Gomez M., Reyburn H.T., Erskine R.A., Lopez-Botet M., Strominger J.L. Kinetics and peptide dependency of the binding of the inhibitory NK receptor CD94/NKG2-A and the activatory receptor CD94/NKG2-C to HLA-E. EMBO J. 18:1999;4250-4260.
33. O'Callaghan C.A., Tormo J., Willcox B.E., Braud V.M., Jakobsen B.K., Stuart D.I., McMichael A.J., Bell J.I., Jones E.Y. Structural features impose tight peptide binding specificity in the non-classical MHC molecule HLA-E. Mol. Cell. 1:1998;531-541.
34. Boyington J.C., Riaz A.N., Patamawenu A., Coligan J.E., Brooks A.G., Sun P.D. Structure of CD94 reveals a novel C-type lectin fold: implications for the NK cell-associated CD94/NKG2 receptors. Immunity. 10:1999;75-82.
35. Reid S.W., McAdam S., Smith K.J., Klenerman P., O'Callaghan C.A., Harlos K., Jakobsen B.K., McMichael A.J., Bell J.I., Stuart D.I., Jones E.Y. Antagonist HIV-1 Gag peptides induce structural changes in HLA B8. J. Exp. M. 184:1996;2279-2286.
36. Barnes P.D., Grundy J.E. Down regulation of class I HLA heterodimer and beta 2-microglobulin on the surface of cells infected with cytomegalovirus. J. Gen. Virol. 73:1992;2395-2403.
37. Fruh K., Ahn K., Djaballah H., Sempe P., Van Endert P.M., Tampe R., Peterson P.A., Yang Y. A viral inhibitor of peptide transporters for antigen presentation. Nature. 375:1995;415-418.